Advancing Alzheimer Disease Prediction With Large Language Model–Based Linguistic Feature Analysis: Development and Validation Study - Scorecard - MDSpire

Advancing Alzheimer Disease Prediction With Large Language Model–Based Linguistic Feature Analysis: Development and Validation Study

  • By

  • Ming-Hsia Hsu

  • San-Yih Hwang

  • Yi-Hang Tsai

  • Yun-Chi Chang

  • Chih-Kuang Liang

  • Chiung-Yun Chang

  • May 28, 2026

  • 0 min

Share

Clinical Scorecard: Enhancing Prediction of Alzheimer’s Disease Through Linguistic Feature Analysis Using Large Language Models: A Study on Development and Validation

At a Glance

CategoryDetail
ConditionAlzheimer Disease (AD)
Key MechanismsIntegration of linguistic assessments and digital cognitive evaluations to enhance early detection and monitoring.
Target PopulationOlder adults, particularly those at risk for or diagnosed with Alzheimer's disease.
Care SettingPrimary care and research settings utilizing digital assessments.

Key Highlights

  • Projected increase in global dementia prevalence from 55 million in 2019 to 139 million by 2050.
  • Early diagnosis of dementia supports informed decision-making and access to treatments.
  • Digital cognitive assessments improve detection rates and accessibility for underserved populations.
  • Language impairments are significant early symptoms of AD, warranting integration into cognitive evaluations.
  • Deep learning approaches enhance AD detection through automated feature extraction from speech data.

Guideline-Based Recommendations

Diagnosis

  • Utilize neuroimaging and cerebrospinal fluid biomarkers as gold standards, while considering plasma biomarkers for accessibility.

Management

  • Incorporate routine cognitive assessments and language evaluations in primary care for early detection.

Monitoring & Follow-up

  • Employ digital cognitive assessments for longitudinal monitoring of cognitive changes.

Risks

  • Consider variability and lower specificity of plasma biomarkers compared to traditional methods.

Patient & Prescribing Data

Individuals aged 65 years and older, particularly those with mild cognitive impairment or at risk for AD.

Early detection through linguistic assessments may facilitate targeted interventions to maintain communication abilities.

Clinical Best Practices

  • Integrate language assessments into conventional cognitive evaluations.
  • Utilize digital assessments for remote self-administration and improved access.
  • Adopt deep learning models with explainability for preliminary AD screening.

Related Resources & Content

Original Source(s)

Related Content